HCC First- and Second-Line Treatment Updates: What’s New in Current Guidelines
To further improve the standardization of diagnosis and treatment for primary liver cancer, the newly…
News
What Are the Top 5 Autoimmune Diseases to Watch in 2026? Insights into Immunotherapy Trends and Innovation
Over the past decade, autoimmune diseases have remained one of the most stable and high-growth…
China Pharmaceutical Export Trends and Global Pharmaceutical Market Opportunities
China’s pharmaceutical industry is undergoing a profound structural transformation, and China pharmaceutical export trends are…
Oral GLP-1 Drug Development Trends: Small-Molecule Innovation and Industry Competition
In recent years, GLP-1 receptor agonists (GLP-1 RAs) have become one of the most closely…
Bispecific ADC Development in Breast Cancer: Emerging Targets and Clinical Progress
Breast cancer is the most common malignancy among women worldwide, with incidence continuing to rise.…
Approved Cell and Gene Therapy Drugs in China and Key Differences Between Cell Therapy and Gene Therapy
The landscape of approved cell and gene therapy drugs in China is rapidly evolving, as…
NMPA Approves GSK Depemokimab in China for Severe Eosinophilic Asthma with Twice-Yearly Dosing
On March 27, 2026, the National Medical Products Administration (NMPA) of China officially approved GSK…
Africa Pharmaceutical Industry Challenges — Analysis of Supply Structure and Drug Accessibility
Currently, africa pharmaceutical industry challenges are increasingly recognized as a key issue in the global…
China Pharmaceutical Procurement Process Guide: RFQ, Compliance, Payment & Global Delivery
With the continuous restructuring of the global healthcare supply chain, China has become one of…
Global Advantages of China Pharmaceuticals: How Four Key Factors Improve Drug Accessibility and Supply Efficiency
In the context of continuous development of global healthcare systems, drug accessibility has become a…
Copyright@ 2016-2024 Hong Kong Deng Yue Med Al Rights